ns7

Atrasentan, also known as ABT-627, is a orally available ETA receptor antagonist with potential antineoplastic activity. As a selective antagonist of the endothelin-A (ETA) receptor, atrasentan binds selectively to the ETA receptor, which may result in inhibition of endothelin-induced angiogenesis and tumor cell proliferation.

Dexpramipexole ((R)-Pramipexole) 是利鲁唑的 BTZ 结构类似物，是一种维持线粒体功能和能量产生的线粒体保护剂，可通过上调线粒体自噬减轻心肌缺血 再灌注损伤，可用于治疗肌萎缩侧索硬化症疾病。